نتائج البحث - Stéphane Epelbaum

تنقيح النتائج
  1. 1
    Free and Cued Selective Reminding Test – accuracy for the differential diagnosis of Alzheimer's and neurodegenerative diseases: A large‐scale biomarker‐characterized monocenter cohort study (ClinAD)

    Free and Cued Selective Reminding Test – accuracy for the differential diagnosis of Alzheimer's and neurodegenerative diseases: A large‐scale biomarker‐characterized monocenter coh... حسب Marc Teichmann, Stéphane Epelbaum, Dalila Samri, Marcel Levy Nogueira, Agnès Michon, Harald Hampel, Foudil Lamari, Bruno Dubois

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's Disease.

    Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's Disease. حسب Federica Cacciamani, Caroline Tandetnik, Geoffroy Gagliardi, Hugo Bertin, Marie‐Odile Habert, Harald Hampel, Laurie Boukadida, Marie Révillon, Stéphane Epelbaum, Bruno Dubois

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Identifying health conditions associated with Alzheimer's disease up to 15 years before diagnosis: an agnostic study of French and British health records

    Identifying health conditions associated with Alzheimer's disease up to 15 years before diagnosis: an agnostic study of French and British health records حسب Thomas Nédelec, Baptiste Couvy‐Duchesne, Fleur Monnet, Timothy Daly, Manon Ansart, Laurène Gantzer, Béranger Lekens, Stéphane Epelbaum, Carole Dufouil, Stanley Durrleman

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Forecasting individual progression trajectories in Alzheimer’s disease

    Forecasting individual progression trajectories in Alzheimer’s disease حسب Etienne Maheux, Igor Koval, Juliette Ortholand, Colin Birkenbihl, Damiano Archetti, Vincent Bouteloup, Stéphane Epelbaum, Carole Dufouil, Martin Hofmann‐Apitius, Stanley Durrleman

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept

    Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept حسب Stéphane Epelbaum, Rémy Genthon, Enrica Cavedo, Marie Odile Habert, Foudil Lamari, Geoffroy Gagliardi, Simone Lista, Marc Teichmann, Hovagim Bakardjian, Harald Hampel, Bruno Dubois

    منشور في 2017
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Awareness of Cognitive Decline in Patients With Alzheimer's Disease: A Systematic Review and Meta-Analysis

    Awareness of Cognitive Decline in Patients With Alzheimer's Disease: A Systematic Review and Meta-Analysis حسب Federica Cacciamani, Marion Houot, Geoffroy Gagliardi, Bruno Dubois, Sietske A.M. Sikkes, Gonzalo Sánchez‐Benavides, Elena Denicolò, José Luís Molinuevo, Patrizia Vannini, Stéphane Epelbaum

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Cutting through the noise: A narrative review of Alzheimer's disease plasma biomarkers for routine clinical use

    Cutting through the noise: A narrative review of Alzheimer's disease plasma biomarkers for routine clinical use حسب Michael Schöll, Agathe Vrillon, Takeshi Ikeuchi, Frances C. Quevenco, Leonardo Iaccarino, S. Vasileva-Metodiev, Samantha Burnham, James A. Hendrix, Stéphane Epelbaum, Henrik Zetterberg, Sebastian Palmqvist

    منشور في 2025
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Étude quantitative des anomalies de signal flair de la substance blanche dans les pathologies neurodégénératives

    Étude quantitative des anomalies de signal flair de la substance blanche dans les pathologies neurodégénératives حسب Sébastian Ströer, Ludovic Fillon, Stéphane Epelbaum, Marc Teichmann, Agnès Michon, Lara Miggliaccio, Aline Mendes, Marie Chupin, Olivier Colliot, Jamila Ahdidan, Christian Christoffersen, Claus Vesterager Pedersen, Didier Dormont, Anne Bertrand

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    AD Course Map charts Alzheimer’s disease progression

    AD Course Map charts Alzheimer’s disease progression حسب Igor Koval, Alexandre Bône, Maxime Louis, Thomas Lartigue, Simona Bottani, Arnaud Marcoux, Jorge Samper‐Gonzàlez, Ninon Burgos, Benjamin Charlier, Anne Bertrand, Stéphane Epelbaum, Olivier Colliot, Stéphanie Allassonnière, Stanley Durrleman

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Multi-omics signature of brain amyloid deposition in asymptomatic individuals at-risk for Alzheimer's disease: The INSIGHT-preAD study

    Multi-omics signature of brain amyloid deposition in asymptomatic individuals at-risk for Alzheimer's disease: The INSIGHT-preAD study حسب Laura Xicota, Farid Ichou, François‐Xavier Lejeune, Benoît Colsch, Arthur Tenenhaus, Inka Leroy, Gaëlle Fontaine, Marie Lhomme, Hugo Bertin, Marie‐Odile Habert, Stéphane Epelbaum, Bruno Dubois, Fanny Mochel, Marie‐Claude Potier

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease

    Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease حسب Simone Lista, Nicola Toschi, Filippo Baldacci, Henrik Zetterberg, Kaj Blennow, Ingo Kilimann, Stefan Teipel, Enrica Cavedo, Antonio Melo dos Santos, Stéphane Epelbaum, Foudil Lamari, Bruno Dubois, Roberto Floris, Francesco Garaci, Harald Hampel

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    EEG evidence of compensatory mechanisms in preclinical Alzheimer’s disease

    EEG evidence of compensatory mechanisms in preclinical Alzheimer’s disease حسب Sinead Gaubert, Federico Raimondo, Marion Houot, Marie‐Constance Corsi, Lionel Naccache, Jacobo Sitt, Bertrand Hermann, Delphine Oudiette, Geoffroy Gagliardi, Marie-Odile Habert, Bruno Dubois, Fabrizio De Vico Fallani, Hovagim Bakardjian, Stéphane Epelbaum

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Detection of volume loss in hippocampal layers in Alzheimer's disease using 7 T MRI: A feasibility study

    Detection of volume loss in hippocampal layers in Alzheimer's disease using 7 T MRI: A feasibility study حسب Claire Boutet, Marie Chupin, Stéphane Lehéricy, Linda Marrakchi‐Kacem, Stéphane Epelbaum, Cyril Poupon, Christopher J. Wiggins, Alexandre Vignaud, Dominique Hasboun, B. Defontaines, Olivier Hanon, Bruno Dubois, Marie Sarazin, Lucie Hertz‐Pannier, Olivier Colliot

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Two‐level diagnostic classification using cerebrospinal fluid YKL‐40 in Alzheimer's disease

    Two‐level diagnostic classification using cerebrospinal fluid YKL‐40 in Alzheimer's disease حسب Filippo Baldacci, Nicola Toschi, Simone Lista, Henrik Zetterberg, Kaj Blennow, Ingo Kilimann, Stefan Teipel, Enrica Cavedo, Antonio Melo dos Santos, Stéphane Epelbaum, Foudil Lamari, Bruno Dubois, Roberto Floris, Francesco Garaci, Ubaldo Bonuccelli, Harald Hampel

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study

    Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study حسب Simone Lista, Nicola Toschi, Filippo Baldacci, Henrik Zetterberg, Kaj Blennow, Ingo Kilimann, Stefan Teipel, Enrica Cavedo, Antonio Melo dos Santos, Stéphane Epelbaum, Foudil Lamari, Bruno Dubois, Robert Nisticò, Roberto Floris, Francesco Garaci, Harald Hampel

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Predicting the progression of mild cognitive impairment using machine learning: A systematic, quantitative and critical review

    Predicting the progression of mild cognitive impairment using machine learning: A systematic, quantitative and critical review حسب Manon Ansart, Stéphane Epelbaum, Giulia Bassignana, Alexandre Bône, Simona Bottani, Tiziana Cattai, Raphaël Couronné, Johann Faouzi, Igor Koval, Maxime Louis, Elina Thibeau–Sutre, Junhao Wen, Adam Wild, Ninon Burgos, Didier Dormont, Olivier Colliot, Stanley Durrleman

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: A long-range point of view beyond 2020

    Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: A long-range point of view beyond 2020 حسب Harald Hampel, Simone Lista, Stefan Teipel, Francesco Garaci, Robert Nisticò, Kaj Blennow, Henrik Zetterberg, Lars Bertram, Charles Duyckaerts, Hovagim Bakardjian, Alexander Drzezga, Olivier Colliot, Stéphane Epelbaum, Karl Broich, Stéphane Lehéricy, Alexis Brice, Zaven S. Khachaturian, Paul Aisen, Bruno Dubois

    منشور في 2013
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group

    Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group حسب Bruno Dubois, Nicolas Villain, Giovanni B. Frisoni, Gil D. Rabinovici, Marwan Sabbagh, Stefano F. Cappa, Alexandre Bejanin, Stéphanie Bombois, Stéphane Epelbaum, Marc Teichmann, Marie-Odile Habert, Agneta Nordberg, Kaj Blennow, Douglas Galasko, Yaakov Stern, Christopher C. Rowe, Stephen Salloway, Lon S. Schneider, Jeffrey L. Cummings, Howard Feldman

    منشور في 2021
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Biomarker-guided clustering of Alzheimer's disease clinical syndromes

    Biomarker-guided clustering of Alzheimer's disease clinical syndromes حسب Nicola Toschi, Simone Lista, Filippo Baldacci, Enrica Cavedo, Henrik Zetterberg, Kaj Blennow, Ingo Kilimann, Stefan Teipel, Antonio Melo dos Santos, Stéphane Epelbaum, Foudil Lamari, Rémy Genthon, Marie‐Odile Habert, Bruno Dubois, Roberto Floris, Francesco Garaci, Andrea Vergallo, Harald Hampel, Hovagim Bakardjian, Habib Benali, Hugo Bertín, Joel Bonheur, Laurie Boukadida, Nadia Boukerrou, Enrica Cavedo, Patrizia A. Chiesa, Olivier Colliot, Bruno Dubois, Marion Dubois, Stéphane Epelbaum, Geoffroy Gagliardi, Rémy Genthon, Marie‐Odile Habert, Harald Hampel, Marion Houot, Aurélie Kas, Foudil Lamari, Marcel Lévy, Simone Lista, Christiane Metzinger, Fanny Mochel, Francis Nyasse, Catherine Poisson, Marie‐Claude Potier, Marie Revillon, Antonio Santos, Katia Santos Andrade, Marine Sole, Mohmed Surtee, Michel Thiebaut de Schotten, Andrea Vergallo, Nadjia Younsi

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience

    Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience حسب Leila Sellami, Benoît Rucheton, Imen Ben Younes, Agnès Camuzat, Dario Saracino, Daisy Rinaldi, Stéphane Epelbaum, Carole Azuar, Richard Lévy, Sophie Auriacombe, Didier Hannequin, Jérémie Pariente, Mathieu Barbier, Claire Boutoleau‐Bretonnière, Philippe Couratier, Florence Pasquier, Vincent Deramecourt, Mathilde Sauvée, Marie Sarazin, Julien Lagarde, Carole Roué-Jagot, Sylvie Forlani, Ludmila Jornéa, I. Rodenhiser David, Eric LeGuern, Bruno Dubois, Alexis Brice, Fabienne Clot, Foudil Lamari, Isabelle Le Ber

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: